How to Build a Pre-IPO Corporate Governance Framework That Meets HKEX Standards

The window for pre-IPO governance remediation is narrowing. On 1 January 2025, the HKEX’s enhanced corporate governance requirements under the Listing Rule amendments to Chapter 14 and Appendix 14 took full effect, mandating that all Main Board and GEM issuers disclose board skills matrices, implement a mandatory director training policy, and ensure no single board committee chair holds multiple concurrent roles across audit, remuneration, and nomination committees (HKEX, CG Code Review Conclusions, December 2023). For companies targeting a listing in 2026 or early 2027, the lead time to build a compliant framework is effectively 12 to 18 months — precisely the period between engaging a sponsor and filing the A1 application. A sponsor’s due diligence will now scrutinise governance structures with the same rigour as financials, and any deficiency identified post-A1 can trigger a re-filing or, in the worst case, a withdrawal. The cost of retrofitting governance is not merely financial — it is a reputational signal to cornerstone investors that the issuer was unprepared. This article provides a rule-by-rule blueprint for constructing a pre-IPO governance framework that meets the 2025 HKEX standards, from board composition and committee charters to internal controls and disclosure protocols.

Board Composition and the Skills Matrix

The HKEX’s mandate for a board skills matrix, codified in Listing Rule 13.92 and Appendix 14, Paragraph A.2.1, requires every issuer to disclose how the board’s skills, experience, and diversity align with the company’s business strategy. This is not a box-ticking exercise: the matrix must be published in the annual report and the listing document. For a pre-IPO company, the matrix must be drafted and approved by the board at least six months before the A1 submission, as the sponsor will require evidence of board composition planning.

Defining Required Competencies

The matrix must map specific skill categories to the company’s industry and stage. For a biotech issuer listing under Chapter 18C, the board should demonstrate expertise in clinical trial regulation, intellectual property strategy, and HKEX Chapter 18A disclosure obligations. For a tech company with a VIE structure, the matrix must include PRC regulatory risk management, cross-border data compliance, and experience with Cayman Islands company law (the typical listing vehicle). The board should identify a minimum of six to eight skill categories, each with at least two directors demonstrating proficiency. The HKEX’s 2024 thematic review of board effectiveness found that 62% of new listings in 2023 had matrices with fewer than five categories, which the regulator flagged as insufficient (HKEX, Board Effectiveness Review Report, June 2024).

Independent Director Recruitment

Listing Rule 3.10 requires at least three independent non-executive directors (INEDs), and at least one must have appropriate professional qualifications or accounting or related financial management expertise (Rule 3.10(2)). Pre-IPO companies often make the error of recruiting INEDs who are personal connections of the founder, which fails the independence test under Rule 3.13. The sponsor will review INEDs’ previous relationships with the issuer, their tenure at other listed entities, and any cross-directorships. A practical approach is to engage a specialist INED recruitment firm at least nine months before A1, targeting candidates with prior HKEX-listed board experience and industry-specific knowledge. The board must also ensure that at least one-third of the board is independent, as per Rule 3.10A for Main Board issuers.

Diversity Policy Implementation

Appendix 14, Paragraph B.1.3 requires a board diversity policy covering gender, age, cultural background, and professional experience. The HKEX has set a target of at least one female director on every board by 31 December 2024, and issuers must disclose progress toward this target in their listing documents. For a pre-IPO company, the diversity policy must be formally adopted by the board and included in the corporate governance report within the prospectus. The policy should include measurable objectives — for example, “the board will maintain a minimum of 30% gender diversity within three years of listing” — and a timeline for achievement. Failure to meet the gender diversity target does not breach the Listing Rules, but the issuer must explain any shortfall in the annual report, which can unsettle ESG-focused investors.

Committee Structures and Charter Requirements

The HKEX mandates three board committees — audit, remuneration, and nomination — under Listing Rules 3.21, 3.25, and 3.27 respectively. Each committee must have written terms of reference that comply with the Code Provisions in Appendix 14. Pre-IPO companies must establish these committees and hold at least two formal meetings before the A1 filing to demonstrate operational substance.

Audit Committee Composition and Charter

The audit committee must comprise at least three members, all INEDs, and at least one member must have appropriate professional qualifications in accounting or financial management (Rule 3.21). The charter must include the committee’s role in overseeing the external auditor’s independence, reviewing the half-year and annual financial statements, and monitoring the internal audit function. Critically, the charter must specify the committee’s authority to investigate any matter within its terms of reference and to access independent legal or other professional advice at the company’s expense (Appendix 14, Code Provision C.3.3). For a pre-IPO issuer, the audit committee should also review the sponsor’s due diligence findings on financial controls and any material adjustments to the historical financial statements. The committee must meet at least quarterly after listing, but pre-IPO, a minimum of two meetings — one to approve the prospectus financials and one to review the internal control report — is advisable.

Remuneration Committee and Disclosure

The remuneration committee must be chaired by an INED and consist of a majority of INEDs (Rule 3.25). The charter must define the committee’s responsibility for determining the remuneration of executive directors and senior management, and for recommending the remuneration of INEDs. Pre-IPO companies should use the committee to formalise a remuneration policy that links executive pay to performance metrics tied to the listing — for example, share price performance, revenue growth, or ESG targets. The policy must be disclosed in the prospectus under the “Directors’ Remuneration” section. The committee must also approve any equity incentive plans, such as share option schemes or restricted share units, ensuring they comply with Chapter 17 of the Listing Rules on share schemes.

Nomination Committee and Succession Planning

The nomination committee must be chaired by the board chairman or an INED and consist of a majority of INEDs (Rule 3.27). The charter must include procedures for identifying and recommending candidates for directorship, assessing board composition against the skills matrix, and reviewing succession plans for the chairman and the CEO. The HKEX’s 2024 review noted that only 38% of new issuers had a documented succession plan at the time of listing (HKEX, Succession Planning Review, August 2024). Pre-IPO companies should draft a succession plan covering the CEO, CFO, and company secretary, with a timeline for transition and a list of potential internal and external candidates. The nomination committee must also oversee the annual board evaluation process, which should be conducted by an external facilitator every three years (Appendix 14, Code Provision B.1.5).

Internal Controls and Disclosure Protocols

The sponsor’s due diligence will include a review of the issuer’s internal control system, covering financial reporting, operational processes, and compliance with applicable laws. The HKEX requires the board to issue a statement in the annual report confirming the effectiveness of the internal control system (Appendix 14, Code Provision C.2.1). For a pre-IPO company, this system must be operational and documented at least six months before A1.

Financial Reporting Controls

The internal control framework must align with the Committee of Sponsoring Organizations of the Treadway Commission (COSO) 2013 framework, which is the de facto standard for HKEX-listed issuers. The controls must cover revenue recognition, cash management, related party transactions, and tax compliance. For a PRC-based issuer, the controls must address the risk of misstatement arising from the VIE structure, including the flow of funds between the onshore operating entity and the offshore listed entity. The sponsor will engage an independent internal control consultant to perform a gap analysis and issue a report, which becomes part of the due diligence pack. The audit committee must review this report and approve a remediation plan for any material weaknesses.

Related Party Transaction Controls

Listing Rule 14A governs connected transactions, requiring disclosure and, in some cases, independent shareholder approval. Pre-IPO companies must establish a policy for identifying, approving, and monitoring connected transactions. The policy should define the threshold for de minimis transactions (below 0.1% of the relevant ratio) and require all non-exempt transactions to be reviewed by the audit committee. The company must also maintain a register of connected persons, including directors, their associates, and any entities controlled by them. The sponsor will test this register against the company’s historical transactions to identify any undisclosed connected transactions that require rectification before listing.

Disclosure Committee and Insider Dealing Policy

The board must establish a disclosure committee responsible for reviewing and approving all price-sensitive information before its release. The committee should include the CFO, the company secretary, and the legal counsel, and must have a written procedure for assessing whether information constitutes inside information under the Securities and Futures Ordinance (SFO), Part XIVA. The insider dealing policy must prohibit directors and employees from trading during blackout periods — typically the 30 days before the release of annual and half-year results — and require pre-clearance of any trades by directors. The policy must be communicated to all employees and documented in the company’s code of conduct. The HKEX’s 2024 enforcement report noted that 27% of disciplinary actions against listed companies involved failures in insider dealing controls (SFC, Enforcement Report 2024, March 2025).

Actionable Takeaways

1. Draft and adopt the board skills matrix at least nine months before the A1 filing, ensuring it maps at least six skill categories to the company’s industry and strategy, and include the matrix in the prospectus.
2. Recruit three INEDs with prior HKEX-listed board experience at least six months before A1, and ensure at least one holds a professional accounting qualification to satisfy Listing Rule 3.10(2).
3. Establish the audit, remuneration, and nomination committees with written charters that comply with Appendix 14 Code Provisions, and hold at least two formal meetings for each committee before the A1 submission.
4. Engage an independent internal control consultant to perform a gap analysis against the COSO 2013 framework at least six months before A1, and ensure the audit committee approves the remediation plan for any material weaknesses.
5. Implement a disclosure committee and an insider dealing policy that prohibits trading during blackout periods, and document all procedures in the company’s code of conduct, with training delivered to all directors and employees.